G.ST Antivirals GmbH

G.ST Antivirals is an Austrian start-up founded in 2019 as a spin-off from the Medical University of Vienna. The young company has its roots in extensive research on the inhibition of rhinovirus infections. Based on this, G.ST Antivirals developed a patented, innovative drug against colds. Since its foundation, the start-up has specialized in the development of effective therapies against various viral infections using its own developed approach. After a successful funding round in 2020, start of clinical phase 1 at the Department of Clinical Pharmacology followed in 2022. The start-up currently employs eight people in Vienna and Guido Gualdoni is the company’s CEO. For their invention, the two founders Guido Gualdoni and Johannes Stöckl received the award “Inventor of the Year” by the Medical University of Vienna in 2020.